Table 8.
Fracture Reduction in the Estrogen-Alone Women's Health Initiative[11]
| Estrogen Alone (ET) (N =5310) | Placebo (N =5429) | ||||||
|---|---|---|---|---|---|---|---|
| Fractures | Reduced per 10,000 per year |
Total number ET |
Per 10,000/yr ET |
Total number Placebo |
Per 10,000/yr Placebo |
% reduction |
Hazard ratio/nCI |
| Total | 46 | 503 | 139 | 724 | 195 | 31 | 0.70/0.63-0.79 |
| Hip | 6 | 38 | 11 | 64 | 17 | 41 | 0.61/0.42-0.91 |
| Clinical vertebral | 6 | 39 | 11 | 64 | 17 | 39 | 0.62/0.42-0.93 |